GENEVA, Oct. 5 -- IMMATICS BIOTECHNOLOGIES GMBH filed a patent application (EP2026/059020) for “ENGINEERED ALLOGENEIC IMMUNE CELLS”. With publication no. WO/2026/202378, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: A61K 40/11
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....